ArticleJournal of oncology2021

Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events.

Jessica M Logan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.